BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target

Benzinga · 2d ago
BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.